Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Gregory Y H Lip, Julius Nikorowitsch, Susanne Sehner, Nina Becher, Emanuele Bertaglia, Carina Blomström-Lundqvist, Axel Brandes, Vincent Beuger, Melanie Calvert, Alan John Camm, Gregory Chlouverakis, Gheorghe-Andrei Dan, Wolfgang Dichtl, Hans Christoph Diener, Alexander Fierenz, Andreas Goette, Joris R de Groot, Astrid Hermans, Andrzej Lubinski, Eloi MarijonBela Merkely, Lluis Mont, Ann-Kathrin Ozga, Kim Rajappan, Andreas Sarkozy, Daniel Scherr, Renate Schnabel, Ulrich Schotten, Emmanuel Simantirakis, Tobias Toennis, Panos Vardas, Daniel Wichterle, Antonia Zapf, Paulus Kirchhof*

*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

25 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences